A study to evaluate the effectiveness of topical interventions in two drug combination therapy versus mono drug therapy for the treatment of intravenous cannula related phlebitis of grade 3 or higher that is caused by the use of peripheral intravenous can

Tinku Adhikary 1, *, Madhukari Ray 2, Yeasira Khatun 3 and Mrinal Das 4

1 Nursing Superintendent, Apollo Multispecialty Hospitals, Kolkata, India.
2 Director Nursing -Eastern Region Apollo Multispecialty Hospitals, Kolkata, India.      
3 Deputy Nursing Superintendent, Apollo Multispecialty Hospitals, Kolkata, India.         
4 Clinical pharmacology, Apollo Multispecialty Hospitals Kolkata, India.
 
Research Article
International Journal of Science and Research Archive, 2023, 10(01), 458–468.
Article DOI: 10.30574/ijsra.2023.10.1.0735
Publication history: 
Received on 14 August 2023; revised on 23 September 2023; accepted on 25 September 2023
 
Abstract: 
Phlebitis—inflammation of the tunica intima of the venous wall—occurred in 13–56% of hospitalized patients 1.   It causes catheter site puss, palpable venous cord, erythema, oedema, and pain. Cannula-related bloodstream infection (CRBSI) complicates phlebitis 2. Phlebitis can cause patient discomfort, a longer hospital stay, and higher medical costs. Topical treatment of phlebitis is highly recommended by the Centre for Disease Control (CDC) & The Infusion Nurses Society (INS) 3 The aim of this study was to examine the efficacy of topical treatment with mono therapy versus Two drug combination therapy.
Methodology: Conducted a hospital-based prospective, observational study. 110 patients were enlisted using a procedure known as sequential sampling. All patients have been assigned to either a group receiving Two drug combination therapy or a group receiving mono therapy by using a lottery system. The Jackson's Visual Infusion Phlebitis 3 (VIP) Scoring System was used to determine the presence and severity of phlebitis. Numerical pain scale was used to identify the pain score.
Result: Phlebitis affected 41% of 50-64-year-olds.62% of patients had mild to moderate pain.75% pain relief and 89% Visual Infusion Phlebitis ( VIP ) score change after the Two drug combination therapy.
Conclusion: The results of the current study support the use of a Two drug combination of drugs for the topical treatment of intravenous cannula-induced phlebitis.
 
Keywords: 
Phlebitis; Intravenous cannula; Two drug combination therapy; Pain score; VIP scores
 
Full text article in PDF: 
 
Copyright information: 

Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0